Global Tissue Engineered Heart Valve Market Insights and Forecast to 2028

Q: How big is the tissue engineered heart valve market?

Market Analysis and Insights Global Tissue Engineered Heart Valve MarketDue to the COVID19 pandemic the global Tissue Engineered Heart Valve market size is estimated to be worth US million in 2022 and is forecast to a readjusted size of US million by 2028 with a CAGR of during the review period.

Q: Who are the key players in the tissue engineered heart valve market?

Some of the key players are Medtronic Inc, Edwards Lifesciences Corporation, Boston Scientific, St.Jude Medical, LivaNova, Symetis SA, CryoLife, TTK Healthcare Limited, Colibri Heart Valve, Lepu Medical Technology, Company, China, Medtronic Inc, Others.

Code: QYRE-Auto-14E484

Report

January 2022

Pages:110

QYResearch

Description

Table of Content

Tables & Figures

FEATURED COMPANIES

Medtronic Inc

Edwards Lifesciences Corporation

TTK Healthcare Limited

Colibri Heart Valve

Lepu Medical Technology

Market Analysis and Insights: Global Tissue Engineered Heart Valve Market

Due to the COVID-19 pandemic, the global Tissue Engineered Heart Valve market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period.

Fully considering the economic change by this health crisis, Transcatheter Heart Valves accounting for % of the Tissue Engineered Heart Valve global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Heart Surgery segment is altered to an % CAGR throughout this forecast period.

China Tissue Engineered Heart Valve market size is valued at US$ million in 2021, while the US and Europe Tissue Engineered Heart Valve are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Tissue Engineered Heart Valve landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

The global key manufacturers of Tissue Engineered Heart Valve include Medtronic, Edwards Lifesciences Corporation, Boston Scientific, Abbott, LivaNova PLC, Symetis SA, CryoLife, TTK Healthcare Limited and Colibri Heart Valve and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

Global Tissue Engineered Heart Valve Scope and Segment

Tissue Engineered Heart Valve market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Tissue Engineered Heart Valve market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Transcatheter Heart Valves

Tissue Heart Valves

Mechanical Heart Valves

Segment by Application

Heart Surgery

Cardiovascular Disease

Others

BY COMPANY

Medtronic

Edwards Lifesciences Corporation

Boston Scientific

Abbott

LivaNova PLC

Symetis SA

CryoLife

TTK Healthcare Limited

Colibri Heart Valve

Lepu Medical Technology

BY REGION

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

U.A.E

FEATURED COMPANIES

Medtronic Inc

Edwards Lifesciences Corporation

TTK Healthcare Limited

Colibri Heart Valve

Lepu Medical Technology

1 Study Coverage

1.1 Tissue Engineered Heart Valve Product Introduction

1.2 Market by Type

1.2.1 Global Tissue Engineered Heart Valve Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Transcatheter Heart Valves

1.2.3 Tissue Heart Valves

1.2.4 Mechanical Heart Valves

1.3 Market by Application

1.3.1 Global Tissue Engineered Heart Valve Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Heart Surgery

1.3.3 Cardiovascular Disease

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Tissue Engineered Heart Valve Sales Estimates and Forecasts 2017-2028

2.2 Global Tissue Engineered Heart Valve Revenue Estimates and Forecasts 2017-2028

2.3 Global Tissue Engineered Heart Valve Revenue by Region: 2017 VS 2021 VS 2028

2.4 Global Tissue Engineered Heart Valve Sales by Region

2.4.1 Global Tissue Engineered Heart Valve Sales by Region (2017-2022)

2.4.2 Global Sales Tissue Engineered Heart Valve by Region (2023-2028)

2.5 Global Tissue Engineered Heart Valve Revenue by Region

2.5.1 Global Tissue Engineered Heart Valve Revenue by Region (2017-2022)

2.5.2 Global Tissue Engineered Heart Valve Revenue by Region (2023-2028)

2.6 North America

2.7 Europe

2.8 Asia-Pacific

2.9 Latin America

2.10 Middle East & Africa

3 Competition by Manufacturers

3.1 Global Tissue Engineered Heart Valve Sales by Manufacturers

3.1.1 Global Top Tissue Engineered Heart Valve Manufacturers by Sales (2017-2022)

3.1.2 Global Tissue Engineered Heart Valve Sales Market Share by Manufacturers (2017-2022)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Tissue Engineered Heart Valve in 2021

3.2 Global Tissue Engineered Heart Valve Revenue by Manufacturers

3.2.1 Global Tissue Engineered Heart Valve Revenue by Manufacturers (2017-2022)

3.2.2 Global Tissue Engineered Heart Valve Revenue Market Share by Manufacturers (2017-2022)

3.2.3 Global Top 10 and Top 5 Companies by Tissue Engineered Heart Valve Revenue in 2021

3.3 Global Tissue Engineered Heart Valve Sales Price by Manufacturers (2017-2022)

3.4 Analysis of Competitive Landscape

3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Tissue Engineered Heart Valve Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.4.3 Global Tissue Engineered Heart Valve Manufacturers Geographical Distribution

3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Tissue Engineered Heart Valve Sales by Type

4.1.1 Global Tissue Engineered Heart Valve Historical Sales by Type (2017-2022)

4.1.2 Global Tissue Engineered Heart Valve Forecasted Sales by Type (2023-2028)

4.1.3 Global Tissue Engineered Heart Valve Sales Market Share by Type (2017-2028)

4.2 Global Tissue Engineered Heart Valve Revenue by Type

4.2.1 Global Tissue Engineered Heart Valve Historical Revenue by Type (2017-2022)

4.2.2 Global Tissue Engineered Heart Valve Forecasted Revenue by Type (2023-2028)

4.2.3 Global Tissue Engineered Heart Valve Revenue Market Share by Type (2017-2028)

4.3 Global Tissue Engineered Heart Valve Price by Type

4.3.1 Global Tissue Engineered Heart Valve Price by Type (2017-2022)

4.3.2 Global Tissue Engineered Heart Valve Price Forecast by Type (2023-2028)

5 Market Size by Application

5.1 Global Tissue Engineered Heart Valve Sales by Application

5.1.1 Global Tissue Engineered Heart Valve Historical Sales by Application (2017-2022)

5.1.2 Global Tissue Engineered Heart Valve Forecasted Sales by Application (2023-2028)

5.1.3 Global Tissue Engineered Heart Valve Sales Market Share by Application (2017-2028)

5.2 Global Tissue Engineered Heart Valve Revenue by Application

5.2.1 Global Tissue Engineered Heart Valve Historical Revenue by Application (2017-2022)

5.2.2 Global Tissue Engineered Heart Valve Forecasted Revenue by Application (2023-2028)

5.2.3 Global Tissue Engineered Heart Valve Revenue Market Share by Application (2017-2028)

5.3 Global Tissue Engineered Heart Valve Price by Application

5.3.1 Global Tissue Engineered Heart Valve Price by Application (2017-2022)

5.3.2 Global Tissue Engineered Heart Valve Price Forecast by Application (2023-2028)

6 North America

6.1 North America Tissue Engineered Heart Valve Market Size by Type

6.1.1 North America Tissue Engineered Heart Valve Sales by Type (2017-2028)

6.1.2 North America Tissue Engineered Heart Valve Revenue by Type (2017-2028)

6.2 North America Tissue Engineered Heart Valve Market Size by Application

6.2.1 North America Tissue Engineered Heart Valve Sales by Application (2017-2028)

6.2.2 North America Tissue Engineered Heart Valve Revenue by Application (2017-2028)

6.3 North America Tissue Engineered Heart Valve Market Size by Country

6.3.1 North America Tissue Engineered Heart Valve Sales by Country (2017-2028)

6.3.2 North America Tissue Engineered Heart Valve Revenue by Country (2017-2028)

6.3.3 U.S.

6.3.4 Canada

7 Europe

7.1 Europe Tissue Engineered Heart Valve Market Size by Type

7.1.1 Europe Tissue Engineered Heart Valve Sales by Type (2017-2028)

7.1.2 Europe Tissue Engineered Heart Valve Revenue by Type (2017-2028)

7.2 Europe Tissue Engineered Heart Valve Market Size by Application

7.2.1 Europe Tissue Engineered Heart Valve Sales by Application (2017-2028)

7.2.2 Europe Tissue Engineered Heart Valve Revenue by Application (2017-2028)

7.3 Europe Tissue Engineered Heart Valve Market Size by Country

7.3.1 Europe Tissue Engineered Heart Valve Sales by Country (2017-2028)

7.3.2 Europe Tissue Engineered Heart Valve Revenue by Country (2017-2028)

7.3.3 Germany

7.3.4 France

7.3.5 U.K.

7.3.6 Italy

7.3.7 Russia

8 Asia Pacific

8.1 Asia Pacific Tissue Engineered Heart Valve Market Size by Type

8.1.1 Asia Pacific Tissue Engineered Heart Valve Sales by Type (2017-2028)

8.1.2 Asia Pacific Tissue Engineered Heart Valve Revenue by Type (2017-2028)

8.2 Asia Pacific Tissue Engineered Heart Valve Market Size by Application

8.2.1 Asia Pacific Tissue Engineered Heart Valve Sales by Application (2017-2028)

8.2.2 Asia Pacific Tissue Engineered Heart Valve Revenue by Application (2017-2028)

8.3 Asia Pacific Tissue Engineered Heart Valve Market Size by Region

8.3.1 Asia Pacific Tissue Engineered Heart Valve Sales by Region (2017-2028)

8.3.2 Asia Pacific Tissue Engineered Heart Valve Revenue by Region (2017-2028)

8.3.3 China

8.3.4 Japan

8.3.5 South Korea

8.3.6 India

8.3.7 Australia

8.3.8 Taiwan

8.3.9 Indonesia

8.3.10 Thailand

8.3.11 Malaysia

8.3.12 Philippines

9 Latin America

9.1 Latin America Tissue Engineered Heart Valve Market Size by Type

9.1.1 Latin America Tissue Engineered Heart Valve Sales by Type (2017-2028)

9.1.2 Latin America Tissue Engineered Heart Valve Revenue by Type (2017-2028)

9.2 Latin America Tissue Engineered Heart Valve Market Size by Application

9.2.1 Latin America Tissue Engineered Heart Valve Sales by Application (2017-2028)

9.2.2 Latin America Tissue Engineered Heart Valve Revenue by Application (2017-2028)

9.3 Latin America Tissue Engineered Heart Valve Market Size by Country

9.3.1 Latin America Tissue Engineered Heart Valve Sales by Country (2017-2028)

9.3.2 Latin America Tissue Engineered Heart Valve Revenue by Country (2017-2028)

9.3.3 Mexico

9.3.4 Brazil

9.3.5 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Tissue Engineered Heart Valve Market Size by Type

10.1.1 Middle East and Africa Tissue Engineered Heart Valve Sales by Type (2017-2028)

10.1.2 Middle East and Africa Tissue Engineered Heart Valve Revenue by Type (2017-2028)

10.2 Middle East and Africa Tissue Engineered Heart Valve Market Size by Application

10.2.1 Middle East and Africa Tissue Engineered Heart Valve Sales by Application (2017-2028)

10.2.2 Middle East and Africa Tissue Engineered Heart Valve Revenue by Application (2017-2028)

10.3 Middle East and Africa Tissue Engineered Heart Valve Market Size by Country

10.3.1 Middle East and Africa Tissue Engineered Heart Valve Sales by Country (2017-2028)

10.3.2 Middle East and Africa Tissue Engineered Heart Valve Revenue by Country (2017-2028)

10.3.3 Turkey

10.3.4 Saudi Arabia

11 Company Profiles

11.1 Medtronic

11.1.1 Medtronic Corporation Information

11.1.2 Medtronic Overview

11.1.3 Medtronic Tissue Engineered Heart Valve Sales, Price, Revenue and Gross Margin (2017-2022)

11.1.4 Medtronic Tissue Engineered Heart Valve Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Medtronic Recent Developments

11.2 Edwards Lifesciences Corporation

11.2.1 Edwards Lifesciences Corporation Corporation Information

11.2.2 Edwards Lifesciences Corporation Overview

11.2.3 Edwards Lifesciences Corporation Tissue Engineered Heart Valve Sales, Price, Revenue and Gross Margin (2017-2022)

11.2.4 Edwards Lifesciences Corporation Tissue Engineered Heart Valve Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Edwards Lifesciences Corporation Recent Developments

11.3 Boston Scientific

11.3.1 Boston Scientific Corporation Information

11.3.2 Boston Scientific Overview

11.3.3 Boston Scientific Tissue Engineered Heart Valve Sales, Price, Revenue and Gross Margin (2017-2022)

11.3.4 Boston Scientific Tissue Engineered Heart Valve Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Boston Scientific Recent Developments

11.4 Abbott

11.4.1 Abbott Corporation Information

11.4.2 Abbott Overview

11.4.3 Abbott Tissue Engineered Heart Valve Sales, Price, Revenue and Gross Margin (2017-2022)

11.4.4 Abbott Tissue Engineered Heart Valve Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Abbott Recent Developments

11.5 LivaNova PLC

11.5.1 LivaNova PLC Corporation Information

11.5.2 LivaNova PLC Overview

11.5.3 LivaNova PLC Tissue Engineered Heart Valve Sales, Price, Revenue and Gross Margin (2017-2022)

11.5.4 LivaNova PLC Tissue Engineered Heart Valve Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 LivaNova PLC Recent Developments

11.6 Symetis SA

11.6.1 Symetis SA Corporation Information

11.6.2 Symetis SA Overview

11.6.3 Symetis SA Tissue Engineered Heart Valve Sales, Price, Revenue and Gross Margin (2017-2022)

11.6.4 Symetis SA Tissue Engineered Heart Valve Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Symetis SA Recent Developments

11.7 CryoLife

11.7.1 CryoLife Corporation Information

11.7.2 CryoLife Overview

11.7.3 CryoLife Tissue Engineered Heart Valve Sales, Price, Revenue and Gross Margin (2017-2022)

11.7.4 CryoLife Tissue Engineered Heart Valve Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 CryoLife Recent Developments

11.8 TTK Healthcare Limited

11.8.1 TTK Healthcare Limited Corporation Information

11.8.2 TTK Healthcare Limited Overview

11.8.3 TTK Healthcare Limited Tissue Engineered Heart Valve Sales, Price, Revenue and Gross Margin (2017-2022)

11.8.4 TTK Healthcare Limited Tissue Engineered Heart Valve Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 TTK Healthcare Limited Recent Developments

11.9 Colibri Heart Valve

11.9.1 Colibri Heart Valve Corporation Information

11.9.2 Colibri Heart Valve Overview

11.9.3 Colibri Heart Valve Tissue Engineered Heart Valve Sales, Price, Revenue and Gross Margin (2017-2022)

11.9.4 Colibri Heart Valve Tissue Engineered Heart Valve Product Model Numbers, Pictures, Descriptions and Specifications

11.9.5 Colibri Heart Valve Recent Developments

11.10 Lepu Medical Technology

11.10.1 Lepu Medical Technology Corporation Information

11.10.2 Lepu Medical Technology Overview

11.10.3 Lepu Medical Technology Tissue Engineered Heart Valve Sales, Price, Revenue and Gross Margin (2017-2022)

11.10.4 Lepu Medical Technology Tissue Engineered Heart Valve Product Model Numbers, Pictures, Descriptions and Specifications

11.10.5 Lepu Medical Technology Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Tissue Engineered Heart Valve Industry Chain Analysis

12.2 Tissue Engineered Heart Valve Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Tissue Engineered Heart Valve Production Mode & Process

12.4 Tissue Engineered Heart Valve Sales and Marketing

12.4.1 Tissue Engineered Heart Valve Sales Channels

12.4.2 Tissue Engineered Heart Valve Distributors

12.5 Tissue Engineered Heart Valve Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

13.1 Tissue Engineered Heart Valve Industry Trends

13.2 Tissue Engineered Heart Valve Market Drivers

13.3 Tissue Engineered Heart Valve Market Challenges

13.4 Tissue Engineered Heart Valve Market Restraints

14 Key Findings in The Global Tissue Engineered Heart Valve Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

Medtronic Inc

Edwards Lifesciences Corporation

TTK Healthcare Limited

Colibri Heart Valve

Lepu Medical Technology

List of Tables

Table 1. Global Tissue Engineered Heart Valve Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)

Table 2. Major Manufacturers of Transcatheter Heart Valves

Table 3. Major Manufacturers of Tissue Heart Valves

Table 4. Major Manufacturers of Mechanical Heart Valves

Table 5. Global Tissue Engineered Heart Valve Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)

Table 6. Global Tissue Engineered Heart Valve Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)

Table 7. Global Tissue Engineered Heart Valve Sales by Region (2017-2022) & (K Units)

Table 8. Global Tissue Engineered Heart Valve Sales Market Share by Region (2017-2022)

Table 9. Global Tissue Engineered Heart Valve Sales by Region (2023-2028) & (K Units)

Table 10. Global Tissue Engineered Heart Valve Sales Market Share by Region (2023-2028)

Table 11. Global Tissue Engineered Heart Valve Revenue by Region (2017-2022) & (US$ Million)

Table 12. Global Tissue Engineered Heart Valve Revenue Market Share by Region (2017-2022)

Table 13. Global Tissue Engineered Heart Valve Revenue by Region (2023-2028) & (US$ Million)

Table 14. Global Tissue Engineered Heart Valve Revenue Market Share by Region (2023-2028)

Table 15. Global Tissue Engineered Heart Valve Sales by Manufacturers (2017-2022) & (K Units)

Table 16. Global Tissue Engineered Heart Valve Sales Share by Manufacturers (2017-2022)

Table 17. Global Tissue Engineered Heart Valve Revenue by Manufacturers (2017-2022) & (US$ Million)

Table 18. Global Tissue Engineered Heart Valve Revenue Share by Manufacturers (2017-2022)

Table 19. Tissue Engineered Heart Valve Price by Manufacturers (2017-2022) &(USD/Unit)

Table 20. Global Tissue Engineered Heart Valve Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 21. Global Tissue Engineered Heart Valve by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tissue Engineered Heart Valve as of 2021)

Table 22. Tissue Engineered Heart Valve Manufacturing Base Distribution and Headquarters

Table 23. Manufacturers Tissue Engineered Heart Valve Product Offered

Table 24. Date of Manufacturers Enter into Tissue Engineered Heart Valve Market

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Tissue Engineered Heart Valve Sales by Type (2017-2022) & (K Units)

Table 27. Global Tissue Engineered Heart Valve Sales by Type (2023-2028) & (K Units)

Table 28. Global Tissue Engineered Heart Valve Sales Share by Type (2017-2022)

Table 29. Global Tissue Engineered Heart Valve Sales Share by Type (2023-2028)

Table 30. Global Tissue Engineered Heart Valve Revenue by Type (2017-2022) & (US$ Million)

Table 31. Global Tissue Engineered Heart Valve Revenue by Type (2023-2028) & (US$ Million)

Table 32. Global Tissue Engineered Heart Valve Revenue Share by Type (2017-2022)

Table 33. Global Tissue Engineered Heart Valve Revenue Share by Type (2023-2028)

Table 34. Tissue Engineered Heart Valve Price by Type (2017-2022) & (USD/Unit)

Table 35. Global Tissue Engineered Heart Valve Price Forecast by Type (2023-2028) & (USD/Unit)

Table 36. Global Tissue Engineered Heart Valve Sales by Application (2017-2022) & (K Units)

Table 37. Global Tissue Engineered Heart Valve Sales by Application (2023-2028) & (K Units)

Table 38. Global Tissue Engineered Heart Valve Sales Share by Application (2017-2022)

Table 39. Global Tissue Engineered Heart Valve Sales Share by Application (2023-2028)

Table 40. Global Tissue Engineered Heart Valve Revenue by Application (2017-2022) & (US$ Million)

Table 41. Global Tissue Engineered Heart Valve Revenue by Application (2023-2028) & (US$ Million)

Table 42. Global Tissue Engineered Heart Valve Revenue Share by Application (2017-2022)

Table 43. Global Tissue Engineered Heart Valve Revenue Share by Application (2023-2028)

Table 44. Tissue Engineered Heart Valve Price by Application (2017-2022) & (USD/Unit)

Table 45. Global Tissue Engineered Heart Valve Price Forecast by Application (2023-2028) & (USD/Unit)

Table 46. North America Tissue Engineered Heart Valve Sales by Type (2017-2022) & (K Units)

Table 47. North America Tissue Engineered Heart Valve Sales by Type (2023-2028) & (K Units)

Table 48. North America Tissue Engineered Heart Valve Revenue by Type (2017-2022) & (US$ Million)

Table 49. North America Tissue Engineered Heart Valve Revenue by Type (2023-2028) & (US$ Million)

Table 50. North America Tissue Engineered Heart Valve Sales by Application (2017-2022) & (K Units)

Table 51. North America Tissue Engineered Heart Valve Sales by Application (2023-2028) & (K Units)

Table 52. North America Tissue Engineered Heart Valve Revenue by Application (2017-2022) & (US$ Million)

Table 53. North America Tissue Engineered Heart Valve Revenue by Application (2023-2028) & (US$ Million)

Table 54. North America Tissue Engineered Heart Valve Sales by Country (2017-2022) & (K Units)

Table 55. North America Tissue Engineered Heart Valve Sales by Country (2023-2028) & (K Units)

Table 56. North America Tissue Engineered Heart Valve Revenue by Country (2017-2022) & (US$ Million)

Table 57. North America Tissue Engineered Heart Valve Revenue by Country (2023-2028) & (US$ Million)

Table 58. Europe Tissue Engineered Heart Valve Sales by Type (2017-2022) & (K Units)

Table 59. Europe Tissue Engineered Heart Valve Sales by Type (2023-2028) & (K Units)

Table 60. Europe Tissue Engineered Heart Valve Revenue by Type (2017-2022) & (US$ Million)

Table 61. Europe Tissue Engineered Heart Valve Revenue by Type (2023-2028) & (US$ Million)

Table 62. Europe Tissue Engineered Heart Valve Sales by Application (2017-2022) & (K Units)

Table 63. Europe Tissue Engineered Heart Valve Sales by Application (2023-2028) & (K Units)

Table 64. Europe Tissue Engineered Heart Valve Revenue by Application (2017-2022) & (US$ Million)

Table 65. Europe Tissue Engineered Heart Valve Revenue by Application (2023-2028) & (US$ Million)

Table 66. Europe Tissue Engineered Heart Valve Sales by Country (2017-2022) & (K Units)

Table 67. Europe Tissue Engineered Heart Valve Sales by Country (2023-2028) & (K Units)

Table 68. Europe Tissue Engineered Heart Valve Revenue by Country (2017-2022) & (US$ Million)

Table 69. Europe Tissue Engineered Heart Valve Revenue by Country (2023-2028) & (US$ Million)

Table 70. Asia Pacific Tissue Engineered Heart Valve Sales by Type (2017-2022) & (K Units)

Table 71. Asia Pacific Tissue Engineered Heart Valve Sales by Type (2023-2028) & (K Units)

Table 72. Asia Pacific Tissue Engineered Heart Valve Revenue by Type (2017-2022) & (US$ Million)

Table 73. Asia Pacific Tissue Engineered Heart Valve Revenue by Type (2023-2028) & (US$ Million)

Table 74. Asia Pacific Tissue Engineered Heart Valve Sales by Application (2017-2022) & (K Units)

Table 75. Asia Pacific Tissue Engineered Heart Valve Sales by Application (2023-2028) & (K Units)

Table 76. Asia Pacific Tissue Engineered Heart Valve Revenue by Application (2017-2022) & (US$ Million)

Table 77. Asia Pacific Tissue Engineered Heart Valve Revenue by Application (2023-2028) & (US$ Million)

Table 78. Asia Pacific Tissue Engineered Heart Valve Sales by Region (2017-2022) & (K Units)

Table 79. Asia Pacific Tissue Engineered Heart Valve Sales by Region (2023-2028) & (K Units)

Table 80. Asia Pacific Tissue Engineered Heart Valve Revenue by Region (2017-2022) & (US$ Million)

Table 81. Asia Pacific Tissue Engineered Heart Valve Revenue by Region (2023-2028) & (US$ Million)

Table 82. Latin America Tissue Engineered Heart Valve Sales by Type (2017-2022) & (K Units)

Table 83. Latin America Tissue Engineered Heart Valve Sales by Type (2023-2028) & (K Units)

Table 84. Latin America Tissue Engineered Heart Valve Revenue by Type (2017-2022) & (US$ Million)

Table 85. Latin America Tissue Engineered Heart Valve Revenue by Type (2023-2028) & (US$ Million)

Table 86. Latin America Tissue Engineered Heart Valve Sales by Application (2017-2022) & (K Units)

Table 87. Latin America Tissue Engineered Heart Valve Sales by Application (2023-2028) & (K Units)

Table 88. Latin America Tissue Engineered Heart Valve Revenue by Application (2017-2022) & (US$ Million)

Table 89. Latin America Tissue Engineered Heart Valve Revenue by Application (2023-2028) & (US$ Million)

Table 90. Latin America Tissue Engineered Heart Valve Sales by Country (2017-2022) & (K Units)

Table 91. Latin America Tissue Engineered Heart Valve Sales by Country (2023-2028) & (K Units)

Table 92. Latin America Tissue Engineered Heart Valve Revenue by Country (2017-2022) & (US$ Million)

Table 93. Latin America Tissue Engineered Heart Valve Revenue by Country (2023-2028) & (US$ Million)

Table 94. Middle East and Africa Tissue Engineered Heart Valve Sales by Type (2017-2022) & (K Units)

Table 95. Middle East and Africa Tissue Engineered Heart Valve Sales by Type (2023-2028) & (K Units)

Table 96. Middle East and Africa Tissue Engineered Heart Valve Revenue by Type (2017-2022) & (US$ Million)

Table 97. Middle East and Africa Tissue Engineered Heart Valve Revenue by Type (2023-2028) & (US$ Million)

Table 98. Middle East and Africa Tissue Engineered Heart Valve Sales by Application (2017-2022) & (K Units)

Table 99. Middle East and Africa Tissue Engineered Heart Valve Sales by Application (2023-2028) & (K Units)

Table 100. Middle East and Africa Tissue Engineered Heart Valve Revenue by Application (2017-2022) & (US$ Million)

Table 101. Middle East and Africa Tissue Engineered Heart Valve Revenue by Application (2023-2028) & (US$ Million)

Table 102. Middle East and Africa Tissue Engineered Heart Valve Sales by Country (2017-2022) & (K Units)

Table 103. Middle East and Africa Tissue Engineered Heart Valve Sales by Country (2023-2028) & (K Units)

Table 104. Middle East and Africa Tissue Engineered Heart Valve Revenue by Country (2017-2022) & (US$ Million)

Table 105. Middle East and Africa Tissue Engineered Heart Valve Revenue by Country (2023-2028) & (US$ Million)

Table 106. Medtronic Corporation Information

Table 107. Medtronic Description and Major Businesses

Table 108. Medtronic Tissue Engineered Heart Valve Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

Table 109. Medtronic Tissue Engineered Heart Valve Product Model Numbers, Pictures, Descriptions and Specifications

Table 110. Medtronic Recent Developments

Table 111. Edwards Lifesciences Corporation Corporation Information

Table 112. Edwards Lifesciences Corporation Description and Major Businesses

Table 113. Edwards Lifesciences Corporation Tissue Engineered Heart Valve Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

Table 114. Edwards Lifesciences Corporation Tissue Engineered Heart Valve Product Model Numbers, Pictures, Descriptions and Specifications

Table 115. Edwards Lifesciences Corporation Recent Developments

Table 116. Boston Scientific Corporation Information

Table 117. Boston Scientific Description and Major Businesses

Table 118. Boston Scientific Tissue Engineered Heart Valve Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

Table 119. Boston Scientific Tissue Engineered Heart Valve Product Model Numbers, Pictures, Descriptions and Specifications

Table 120. Boston Scientific Recent Developments

Table 121. Abbott Corporation Information

Table 122. Abbott Description and Major Businesses

Table 123. Abbott Tissue Engineered Heart Valve Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

Table 124. Abbott Tissue Engineered Heart Valve Product Model Numbers, Pictures, Descriptions and Specifications

Table 125. Abbott Recent Developments

Table 126. LivaNova PLC Corporation Information

Table 127. LivaNova PLC Description and Major Businesses

Table 128. LivaNova PLC Tissue Engineered Heart Valve Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

Table 129. LivaNova PLC Tissue Engineered Heart Valve Product Model Numbers, Pictures, Descriptions and Specifications

Table 130. LivaNova PLC Recent Developments

Table 131. Symetis SA Corporation Information

Table 132. Symetis SA Description and Major Businesses

Table 133. Symetis SA Tissue Engineered Heart Valve Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

Table 134. Symetis SA Tissue Engineered Heart Valve Product Model Numbers, Pictures, Descriptions and Specifications

Table 135. Symetis SA Recent Developments

Table 136. CryoLife Corporation Information

Table 137. CryoLife Description and Major Businesses

Table 138. CryoLife Tissue Engineered Heart Valve Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

Table 139. CryoLife Tissue Engineered Heart Valve Product Model Numbers, Pictures, Descriptions and Specifications

Table 140. CryoLife Recent Developments

Table 141. TTK Healthcare Limited Corporation Information

Table 142. TTK Healthcare Limited Description and Major Businesses

Table 143. TTK Healthcare Limited Tissue Engineered Heart Valve Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

Table 144. TTK Healthcare Limited Tissue Engineered Heart Valve Product Model Numbers, Pictures, Descriptions and Specifications

Table 145. TTK Healthcare Limited Recent Developments

Table 146. Colibri Heart Valve Corporation Information

Table 147. Colibri Heart Valve Description and Major Businesses

Table 148. Colibri Heart Valve Tissue Engineered Heart Valve Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

Table 149. Colibri Heart Valve Tissue Engineered Heart Valve Product Model Numbers, Pictures, Descriptions and Specifications

Table 150. Colibri Heart Valve Recent Developments

Table 151. Lepu Medical Technology Corporation Information

Table 152. Lepu Medical Technology Description and Major Businesses

Table 153. Lepu Medical Technology Tissue Engineered Heart Valve Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

Table 154. Lepu Medical Technology Tissue Engineered Heart Valve Product Model Numbers, Pictures, Descriptions and Specifications

Table 155. Lepu Medical Technology Recent Developments

Table 156. Key Raw Materials Lists

Table 157. Raw Materials Key Suppliers Lists

Table 158. Tissue Engineered Heart Valve Distributors List

Table 159. Tissue Engineered Heart Valve Customers List

Table 160. Tissue Engineered Heart Valve Market Trends

Table 161. Tissue Engineered Heart Valve Market Drivers

Table 162. Tissue Engineered Heart Valve Market Challenges

Table 163. Tissue Engineered Heart Valve Market Restraints

Table 164. Research Programs/Design for This Report

Table 165. Key Data Information from Secondary Sources

Table 166. Key Data Information from Primary Sources

List of Figures

Figure 1. Tissue Engineered Heart Valve Product Picture

Figure 3. Global Tissue Engineered Heart Valve Market Share by Type in 2021 & 2028

Figure 3. Transcatheter Heart Valves Product Picture

Figure 4. Tissue Heart Valves Product Picture

Figure 5. Mechanical Heart Valves Product Picture

Figure 6. Global Tissue Engineered Heart Valve Market Share by Application in 2021 & 2028

Figure 7. Heart Surgery

Figure 8. Cardiovascular Disease

Figure 9. Others

Figure 10. Tissue Engineered Heart Valve Report Years Considered

Figure 11. Global Tissue Engineered Heart Valve Sales 2017-2028 (K Units)

Figure 12. Global Tissue Engineered Heart Valve Revenue, (US$ Million), 2017 VS 2021 VS 2028

Figure 13. Global Tissue Engineered Heart Valve Revenue 2017-2028 (US$ Million)

Figure 14. Global Tissue Engineered Heart Valve Revenue Market Share by Region in Percentage: 2021 Versus 2028

Figure 15. Global Tissue Engineered Heart Valve Sales Market Share by Region (2017-2022)

Figure 16. Global Tissue Engineered Heart Valve Sales Market Share by Region (2023-2028)

Figure 17. North America Tissue Engineered Heart Valve Sales YoY (2017-2028) & (K Units)

Figure 18. North America Tissue Engineered Heart Valve Revenue YoY (2017-2028) & (US$ Million)

Figure 19. Europe Tissue Engineered Heart Valve Sales YoY (2017-2028) & (K Units)

Figure 20. Europe Tissue Engineered Heart Valve Revenue YoY (2017-2028) & (US$ Million)

Figure 21. Asia-Pacific Tissue Engineered Heart Valve Sales YoY (2017-2028) & (K Units)

Figure 22. Asia-Pacific Tissue Engineered Heart Valve Revenue YoY (2017-2028) & (US$ Million)

Figure 23. Latin America Tissue Engineered Heart Valve Sales YoY (2017-2028) & (K Units)

Figure 24. Latin America Tissue Engineered Heart Valve Revenue YoY (2017-2028) & (US$ Million)

Figure 25. Middle East & Africa Tissue Engineered Heart Valve Sales YoY (2017-2028) & (K Units)

Figure 26. Middle East & Africa Tissue Engineered Heart Valve Revenue YoY (2017-2028) & (US$ Million)

Figure 27. The Tissue Engineered Heart Valve Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021

Figure 28. The Top 5 and 10 Largest Manufacturers of Tissue Engineered Heart Valve in the World: Market Share by Tissue Engineered Heart Valve Revenue in 2021

Figure 29. Global Tissue Engineered Heart Valve Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021

Figure 30. Global Tissue Engineered Heart Valve Sales Market Share by Type (2017-2028)

Figure 31. Global Tissue Engineered Heart Valve Revenue Market Share by Type (2017-2028)

Figure 32. Global Tissue Engineered Heart Valve Sales Market Share by Application (2017-2028)

Figure 33. Global Tissue Engineered Heart Valve Revenue Market Share by Application (2017-2028)

Figure 34. North America Tissue Engineered Heart Valve Sales Market Share by Type (2017-2028)

Figure 35. North America Tissue Engineered Heart Valve Revenue Market Share by Type (2017-2028)

Figure 36. North America Tissue Engineered Heart Valve Sales Market Share by Application (2017-2028)

Figure 37. North America Tissue Engineered Heart Valve Revenue Market Share by Application (2017-2028)

Figure 38. North America Tissue Engineered Heart Valve Sales Share by Country (2017-2028)

Figure 39. North America Tissue Engineered Heart Valve Revenue Share by Country (2017-2028)

Figure 40. U.S. Tissue Engineered Heart Valve Revenue (2017-2028) & (US$ Million)

Figure 41. Canada Tissue Engineered Heart Valve Revenue (2017-2028) & (US$ Million)

Figure 42. Europe Tissue Engineered Heart Valve Sales Market Share by Type (2017-2028)

Figure 43. Europe Tissue Engineered Heart Valve Revenue Market Share by Type (2017-2028)

Figure 44. Europe Tissue Engineered Heart Valve Sales Market Share by Application (2017-2028)

Figure 45. Europe Tissue Engineered Heart Valve Revenue Market Share by Application (2017-2028)

Figure 46. Europe Tissue Engineered Heart Valve Sales Share by Country (2017-2028)

Figure 47. Europe Tissue Engineered Heart Valve Revenue Share by Country (2017-2028)

Figure 48. Germany Tissue Engineered Heart Valve Revenue (2017-2028) & (US$ Million)

Figure 49. France Tissue Engineered Heart Valve Revenue (2017-2028) & (US$ Million)

Figure 50. U.K. Tissue Engineered Heart Valve Revenue (2017-2028) & (US$ Million)

Figure 51. Italy Tissue Engineered Heart Valve Revenue (2017-2028) & (US$ Million)

Figure 52. Russia Tissue Engineered Heart Valve Revenue (2017-2028) & (US$ Million)

Figure 53. Asia Pacific Tissue Engineered Heart Valve Sales Market Share by Type (2017-2028)

Figure 54. Asia Pacific Tissue Engineered Heart Valve Revenue Market Share by Type (2017-2028)

Figure 55. Asia Pacific Tissue Engineered Heart Valve Sales Market Share by Application (2017-2028)

Figure 56. Asia Pacific Tissue Engineered Heart Valve Revenue Market Share by Application (2017-2028)

Figure 57. Asia Pacific Tissue Engineered Heart Valve Sales Share by Region (2017-2028)

Figure 58. Asia Pacific Tissue Engineered Heart Valve Revenue Share by Region (2017-2028)

Figure 59. China Tissue Engineered Heart Valve Revenue (2017-2028) & (US$ Million)

Figure 60. Japan Tissue Engineered Heart Valve Revenue (2017-2028) & (US$ Million)

Figure 61. South Korea Tissue Engineered Heart Valve Revenue (2017-2028) & (US$ Million)

Figure 62. India Tissue Engineered Heart Valve Revenue (2017-2028) & (US$ Million)

Figure 63. Australia Tissue Engineered Heart Valve Revenue (2017-2028) & (US$ Million)

Figure 64. Taiwan Tissue Engineered Heart Valve Revenue (2017-2028) & (US$ Million)

Figure 65. Indonesia Tissue Engineered Heart Valve Revenue (2017-2028) & (US$ Million)

Figure 66. Thailand Tissue Engineered Heart Valve Revenue (2017-2028) & (US$ Million)

Figure 67. Malaysia Tissue Engineered Heart Valve Revenue (2017-2028) & (US$ Million)

Figure 68. Philippines Tissue Engineered Heart Valve Revenue (2017-2028) & (US$ Million)

Figure 69. Latin America Tissue Engineered Heart Valve Sales Market Share by Type (2017-2028)

Figure 70. Latin America Tissue Engineered Heart Valve Revenue Market Share by Type (2017-2028)

Figure 71. Latin America Tissue Engineered Heart Valve Sales Market Share by Application (2017-2028)

Figure 72. Latin America Tissue Engineered Heart Valve Revenue Market Share by Application (2017-2028)

Figure 73. Latin America Tissue Engineered Heart Valve Sales Share by Country (2017-2028)

Figure 74. Latin America Tissue Engineered Heart Valve Revenue Share by Country (2017-2028)

Figure 75. Mexico Tissue Engineered Heart Valve Revenue (2017-2028) & (US$ Million)

Figure 76. Brazil Tissue Engineered Heart Valve Revenue (2017-2028) & (US$ Million)

Figure 77. Argentina Tissue Engineered Heart Valve Revenue (2017-2028) & (US$ Million)

Figure 78. Middle East and Africa Tissue Engineered Heart Valve Sales Market Share by Type (2017-2028)

Figure 79. Middle East and Africa Tissue Engineered Heart Valve Revenue Market Share by Type (2017-2028)

Figure 80. Middle East and Africa Tissue Engineered Heart Valve Sales Market Share by Application (2017-2028)

Figure 81. Middle East and Africa Tissue Engineered Heart Valve Revenue Market Share by Application (2017-2028)

Figure 82. Middle East and Africa Tissue Engineered Heart Valve Sales Share by Country (2017-2028)

Figure 83. Middle East and Africa Tissue Engineered Heart Valve Revenue Share by Country (2017-2028)

Figure 84. Turkey Tissue Engineered Heart Valve Revenue (2017-2028) & (US$ Million)

Figure 85. Saudi Arabia Tissue Engineered Heart Valve Revenue (2017-2028) & (US$ Million)

Figure 86. U.A.E Tissue Engineered Heart Valve Revenue (2017-2028) & (US$ Million)

Figure 87. Tissue Engineered Heart Valve Value Chain

Figure 88. Tissue Engineered Heart Valve Production Process

Figure 89. Channels of Distribution

Figure 90. Distributors Profiles

Figure 91. Bottom-up and Top-down Approaches for This Report

Figure 92. Data Triangulation

Figure 93. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user(purchaser of the report) to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (10% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Tissue Engineered Heart Valve Market Insights and Forecast to 2028

Published Date: January 2022

Report Code: QYRE-Auto-14E484

Global Tissue Engineered Heart Valve Market Insights and Forecast to 2028

FEATURED COMPANIES

Segment by Type

Segment by Application

BY COMPANY

BY REGION

FEATURED COMPANIES

FEATURED COMPANIES

HAVE A QUERY?

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-37R6046

Mon Apr 15 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-23S9116

Mon Apr 15 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-7S6333

Mon Apr 15 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-37M13084

Sun Apr 07 00:00:00 UTC 2024

Support Contacts

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

POLICIES

THE COMPANY

CUSTOMER SUPPORT

OUR PRODUCTS

POLICES

Copyright © 2018 Valuates.com. All Rights Reserved.

Sitemap - Privacy Policy - Terms & Conditions